LBA32 Principal results of the EORTC-1508 trial: A phase II randomised, multicentre study of bevacizumab vs atezolizumab and bevacizumab with acetylsalicylic acid or placebo in recurrent platinum-resistant ovarian, fallopian tube or primary peritoneal adenocarcinomaSusana Banerjee, George Coukos, Apostolos Sarivalasis et al.|Annals of Oncology|2021Cited by 4